Association of body-mass index and outcomes in patients with metastatic melanoma treated with targeted therapy, immunotherapy, or chemotherapy: a retrospective, multicohort analysisJennifer L. McQuade, Michael A. Davies, Carrie R. Daniel et al.|The Lancet Oncology|2018Cited by 658
Circulating tumor cells as prognostic and predictive markers in metastatic breast cancer patients receiving first-line systemic treatmentMario Giuliano, Massimo Cristofanilli, Antonio Giordano et al.|Breast Cancer Research|2011Cited by 224
Phase 2 study of pembrolizumab in patients with advanced rare cancersAung Naing, Mouhammed Amir Habra, Kanwal Raghav et al.|Journal for ImmunoTherapy of Cancer|2020Cited by 130
Artificial neural network analysis of circulating tumor cells in metastatic breast cancer patientsAntonio Giordano, James M. Reuben, Mario Giuliano et al.|Breast Cancer Research and Treatment|2011Cited by 32